Observational studyMedicine2017

Using health-system-wide data to understand hepatitis B virus prophylaxis and reactivation outcomes in patients receiving rituximab.

Gabriela Schmajuk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.